Back to search

Article

Anti-Fibrotic Agents Could Be the Game Changer for Post‑COVID Pulmonary Fibrosis Treatment – A Mini Review

2021-05-18

Abstract excerpt

Total 219 countries and territories globally suffering from the recent pandemic COVID-19 is now in its second wave with more brutality, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) . It has several symptoms like as persistent fever; respiratory illnesses; cough; fatigue; shortness of breath; loss of appetite; persistent pain or pressure in the chest; dysgeusia; acute respiratory distress...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
107e74a8-129e-588b-be7f-0db9048d7311
DOI
10.20944/preprints202105.0423.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Anti-Fibrotic Agents Could Be the Game Changer for Post‑COVID Pulmonary Fibrosis Treatment – A Mini ReviewDOI 10.20944/preprints202105.0423.v1
[Novel therapies in respiratory management].Semantic proximity
Novel mechanisms and treatment of idiopathic pulmonary fibrosis.Semantic proximity
[Idiopathic pulmonary fibrosis--Pathogenesis and therapeutic concepts].Semantic proximity
Mechanisms and Therapeutic Strategies for Pulmonary Fibrosis Post-COVID-19 ARDS: Insights from Comprehensive BioinformaticsSemantic proximity
Integrative single-cell transcriptome analysis reveals new insights into post-COVID-19 pulmonary fibrosis and potential therapeutic targetsSemantic proximity
Immunological mechanisms and therapeutic approaches in pulmonary fibrosis.Semantic proximity
COVID-19-related end stage lung disease: two distinct phenotypes.Semantic proximity
Combating COVID-19 with mesenchymal stem cell therapySemantic proximity
An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis.Semantic proximity
The pathogenesis of pulmonary fibrosis: a moving target.Semantic proximity
Cellular and molecular mechanisms in fibrosisSemantic proximity
Shared and distinct mechanisms of fibrosis.Semantic proximity
Select a neighboring publication to make it the new centre.